Format

Send to

Choose Destination
Infect Dis Clin North Am. 2011 Dec;25(4):819-34. doi: 10.1016/j.idc.2011.07.008.

Interferons as therapeutic agents for infectious diseases.

Author information

1
Department of Pharmacy Practice, Southern Illinois University Edwardsville (SIUE) School of Pharmacy, Edwardsville, IL 62026, USA. scbergm@siue.edu

Abstract

This article explains the rationale for development of interferons as therapeutic agents, and describes commercial products available today. It also provides a summary of studies that have been performed with interferons for use as exogenous biological response modifiers in viral infections. Overall, the best data exist for treatment of viral hepatitis B and C, for which interferons are a cornerstone of therapy. Although infections with human papillomavirus and common cold viruses sometimes respond favorably to interferons, their outcomes are far from ideal. Finally, the role of interferons as vaccine adjuvants is still being explored but could be promising.

PMID:
22054758
DOI:
10.1016/j.idc.2011.07.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center